paralyzed stomach semaglutide Ozempic linked to paralysis, other gastrointestinal issues: UBC study Stomach Paralysis: The Unseen Side

The study provided evidence at 12 weeks that patients in the GLP-1 group acquired better scores in all cognitive tests and showed remarkable improvement in memory and attention ( P = .040) tests compared with the control group after multivariable adjustment

The goal is finding the lowest effective dose that balances efficacy with side effect tolerability over a 1216 week titration period

Click on the JSmol tab to take a closer look at how GLP-1 (PDB 6X18), semaglutide (PDB 7KI0), tirzepatide (PDB 7FIM), and orforglipron (PDB 6XOX) are able to stabilize the active form of the GLP-1 receptor, and compare these structures to that of the inactive GLP-1 receptor (PDB 6LN2)

Artic Int J Neurosci

Were starting to see momentum in this vein